Showing posts tagged with "application-note"
This application note describes the extraction of neutral and zwitterionic antiepileptic drugs fortified in serum and urine using ISOLUTE® SLE+ in a 96-well plate format. Figure 1. Structures of Carba...
Introduction Per- and polyfluoroalkyl substances (PFAS) have been widely manufactured and utilized across numerous industrial and consumer applications since their introduction in the mid-20th century...
Introduction Accurate quantitation of therapeutic oligonucleotides in tissue is essential for pharmacokinetic, toxicology, and broader bioanalytical studies, particularly during clinical development a...
Introduction Accurate quantitation of oligonucleotides in human plasma is essential for pharmacokinetic and bioanalytical studies, particularly during clinical development and therapeutic monitoring. ...
Introduction Breastfeeding offers significant health benefits for both infants and mothers, promoting optimal nutrition, immune protection, and developmental outcomes. However, maternal use of illicit...
Introduction The screening of patient urine samples for basic drugs is typically performed following a lengthy sample preparation methodology that requires a time consuming dry down step. A novel elut...
Scope This application note will outline the appropriate methods for the extraction of PBDEs as outlined by EU Standards at IRSA using Atlantic® C18 solid phase extraction disks processed using Biotag...
Figure 1. Structural formula of Sennoside.
Introduction The environmental persistence of pharmaceuticals is of increasing interest, with little known regarding removal during wastewater treatment. This study investigates the potential of comme...
For research use only. NOT for use in diagnostic procedures.